Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Multi-Site Break through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib (Trial In Progress)

Blood (2024) 144 (Supplement 1): 4265.2.

https://doi.org/10.1182/blood-2024-201582

Published: 2024

Journal Articles

Cytokine-Linked Remodeling of the Immune Microenvironment Is a Hallmark of Transformation in Follicular Lymphoma

Blood (2024) 144 (Supplement 1): 645.

https://doi.org/10.1182/blood-2024-200167

Published: 2024

Journal Articles

B-cell–directed CAR T-cell therapy activates CD8 + cytotoxic CAR neg bystander T cells in patients and nonhuman primates

Blood (2024) 144 (1): 46–60.

https://doi.org/10.1182/blood.2023022717

Published: 2024

Includes: Supplemental data

Journal Articles

Cell Mass and Stiffness As Integrative Biomarkers of Cell State in Mantle Cell Lymphoma

Lydie Debaize, Ye Zhang, Adam Langenbucher, Huiyun Liu, Michelle Ramseier, Nolawit Mulugeta, Nezha Senhaji, Robert A. Redd, Martin J. Aryee, Alex K. Shalek, David M. Weinstock, Scott R. Manalis, Mark A. Murakami

Blood (2022) 140 (Supplement 1): 3581–3582.

https://doi.org/10.1182/blood-2022-169700

Published: 2022

Journal Articles

CAR-T Cell Infusion Results in Activation of CD160+/NKG2D+/CCL5+ Non-CAR CD8+ Cytotoxic 'Bystander' T Cells in Both Non-Human Primates (NHP) and Patients Receiving B-Cell-Directed CAR-Ts

Ulrike Gerdemann, James Kaminski, Ryan A Fleming, Victor Tkachev, Francesca Alvarez Calderon, Connor McGuckin, Xianliang Rui, Jennifer Lane, Alex K. Shalek, Leslie Kean

Blood (2022) 140 (Supplement 1): 1167–1168.

https://doi.org/10.1182/blood-2022-169435

Published: 2022

Journal Articles

Mechanisms of Leukemia Stem Cell Plasticity Revealed By Single Cell Analysis

R. Grant Rowe, George Q. Daley, MD PhD, Trista E. North, PhD, William Marion, Yana Pikman, MD, Marian H. Harris, MD PhD, Vivian Morris, Edroaldo Lummertz da rocha, PhD, Alex K. Shalek, PhD, Travis Hughes, Prerana Sensharma, Dahai Wang, Patricia Sousa, Shannan Ho Sui, Sergey Naumenko, Renan Vinicius Da Silva

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-135998

Published: 2020

Journal Articles

Single-Cell RNA-Seq Reveals AML Cellular Hierarchies Relevant to Clinical Outcomes and Immunity

Peter Van Galen, PhD, Volker Hovestadt, PhD, Marc Wadsworth II, Travis Hughes, Gabriel Kenneth Griffin, MD, Julia A. Verga, Jason Stephansky, Timothy J. Pastika, Jennifer Lombardi Story, Geraldine S. Pinkus, MD, Olga Pozdnyakova, MD PhD, Ilene Galinsky, Richard M. Stone, MD, Timothy A. Graubert, MD, Alex K. Shalek, PhD, Jon C. Aster, MD PhD, Andrew A. Lane, MD PhD, Bradley E. Bernstein, MD PhD

Blood (2018) 132 (Supplement 1): 542.

https://doi.org/10.1182/blood-2018-99-113502

Published: 2018

Journal Articles

Linking Biophysical and Transcriptional Profiles of In Vivo -Treated Human Leukemias on a Single-Cell Level Uniquely Resolves Subpopulations of Response

Mark A. Murakami, MDMA,MMSc, Mark M Stevens, PhD, Robert J Kimmerling, PhD, Alejandro J Gupta, BS, Huiyun Liu, Sanjay M. Prakadan, AB, Alex K. Shalek, PhD, Scott R. Manalis, PhD, David M. Weinstock, MD

Blood (2017) 130 (Supplement 1): 3987.

https://doi.org/10.1182/blood.V130.Suppl_1.3987.3987

Published: 2017

Journal Articles

Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL

Blood (2014) 124 (7): 1089–1098.

https://doi.org/10.1182/blood-2014-01-552067

Published: 2014

Includes: Supplemental data

Journal Articles

Somatic Mutation As a Mechanism of Wnt/β-Catenin Pathway Activation in CLL

Lili Wang, M.D., Ph.D., Alex K Shalek, Ph.D., Jellert Gaublomme, Michael Lawrence, Ph.D., Kristen E. Stevenson, MS, Donna S. Neuberg, ScD, Nir Hacohen, PhD, Gad Getz, Ph.D., Jennifer R. Brown, MD, PhD, Hongkun Park, Ph.D., Catherine J. Wu, MD

Blood (2012) 120 (21): 559.

https://doi.org/10.1182/blood.V120.21.559.559

Published: 2012

Journal Articles

Sensitivity to Wnt Pathway Inhibition in CLL Is Associated with Specific Gene Expression Signatures

Lili Wang, Alex K Shalek, Jellert Gaublomme, Nir Yosef, Jennifer R Brown, MD, PhD, Donna Neuberg, ScD, Nir Hacohen, Hongkun Park, Catherine J Wu, MD

Blood (2011) 118 (21): 801.

https://doi.org/10.1182/blood.V118.21.801.801

Published: 2011

NARROW

A Multi-Site Break through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib (Trial In Progress)

Cytokine-Linked Remodeling of the Immune Microenvironment Is a Hallmark of Transformation in Follicular Lymphoma

B-cell–directed CAR T-cell therapy activates CD8 + cytotoxic CAR neg bystander T cells in patients and nonhuman primates

Cell Mass and Stiffness As Integrative Biomarkers of Cell State in Mantle Cell Lymphoma

CAR-T Cell Infusion Results in Activation of CD160+/NKG2D+/CCL5+ Non-CAR CD8+ Cytotoxic 'Bystander' T Cells in Both Non-Human Primates (NHP) and Patients Receiving B-Cell-Directed CAR-Ts

Mechanisms of Leukemia Stem Cell Plasticity Revealed By Single Cell Analysis

Single-Cell RNA-Seq Reveals AML Cellular Hierarchies Relevant to Clinical Outcomes and Immunity

Linking Biophysical and Transcriptional Profiles of In Vivo -Treated Human Leukemias on a Single-Cell Level Uniquely Resolves Subpopulations of Response

Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL

Somatic Mutation As a Mechanism of Wnt/β-Catenin Pathway Activation in CLL

Sensitivity to Wnt Pathway Inhibition in CLL Is Associated with Specific Gene Expression Signatures

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only